0000911916-15-000125.txt : 20150505 0000911916-15-000125.hdr.sgml : 20150505 20150505170844 ACCESSION NUMBER: 0000911916-15-000125 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20150505 FILED AS OF DATE: 20150505 DATE AS OF CHANGE: 20150505 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CoLucid Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001348649 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 203419541 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 15 NEW ENGLAND EXECUTIVE PARK CITY: BURLINGTON STATE: MA ZIP: 01803 BUSINESS PHONE: 781-365-2596 MAIL ADDRESS: STREET 1: 15 NEW ENGLAND EXECUTIVE PARK CITY: BURLINGTON STATE: MA ZIP: 01803 FORMER COMPANY: FORMER CONFORMED NAME: Colucid Pharmaceuticals Inc DATE OF NAME CHANGE: 20060104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dallas Matthew D CENTRAL INDEX KEY: 0001612396 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37358 FILM NUMBER: 15833961 MAIL ADDRESS: STREET 1: AVEO PHARMACEUTICALS, INC. STREET 2: 650 EAST KENDALL STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 3 1 edgar.xml PRIMARY DOCUMENT X0206 3 2015-05-05 1 0001348649 CoLucid Pharmaceuticals, Inc. CLCD 0001612396 Dallas Matthew D 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803 0 1 0 0 Chief Financial Officer Exhibit 24 - Power of Attorney /s/ Miranda S. Hirner, Attorney-in-Fact for Matthew D. Dallas (power of attorney filed herewith) 2015-05-05 EX-24 2 dallaspoa.htm POWER OF ATTORNEY - MATTHEW D. DALLAS

POWER OF ATTORNEY



For Executing Forms 144, Forms 3, 4, 5 and Form ID



The undersigned hereby constitutes and appoints Daniel L. Boeglin,

Christine G. Long, Jonathan R. Zimmerman, Laura D. Yockey,

Kassendra D. Galindo, Miranda S. Hirner, and Tracy L. Whitman,

and each of them, the undersigned's true and lawful attorney-in-fact,

for such period of time that the undersigned is required to file

reports pursuant to Section 16(a) of the Securities Exchange Act of

1934,as amended (the "Exchange Act"), or Rule 144 of the Securities

Act of 1933, as amended (the "Securities Act"), due to the

undersigned's affiliation with CoLucid Pharmaceuticals, Inc.,

a Delaware corporation, unless earlier revoked by the undersigned

in a signed writing delivered to the foregoing attorneys-in-fact, to:



1) execute for and on behalf of the undersigned Forms 144, Forms 3,

4, 5 and Form ID and any amendments to previously filed forms in

accordance with Section 16(a) of the Exchange Act or Rule 144 of

the Securities Act and the rules thereunder;



2) do and perform any and all acts for and on behalf of the

undersigned which may be necessary or desirable to complete the

execution of any such Forms 144, Forms 3, 4, 5 and Form ID and the

timely filing of such form with the United States Securities and

Exchange Commission and any other authority as required by law; and



3) take any other action of any type whatsoever in connection with

the foregoing which, in the opinion of such attorney-in-fact, may

be of benefit to, in the best interest of or legally required by the

undersigned, it being understood that the documents executed by such

attorney-in-fact on behalf of the undersigned pursuant to this Power

of Attorney shall be in such form and shall contain such terms and

conditions as such attorney-in-fact may approve in his discretion.



The undersigned hereby grants to each such attorney-in-fact full

power and authority to do and perform all and every act and thing

whatsoever requisite, necessary and proper to be done in the

exercise of any of the rights and powers herein granted, as fully

to all intents and purposes as the undersigned could do if personally

present, with full power of substitution or revocation, hereby

ratifying and confirming all that such attorney-in-fact, or his

or her substitute or substitutes, shall lawfully do or cause to be

done by virtue of this Power of Attorney and the rights and powers

herein granted.  The undersigned acknowledges that the foregoing

attorneys-in-fact, in serving in such capacity at the request of

the undersigned, are not assuming any of the undersigned's

responsibilities to comply with Section 16 of the Exchange Act

or Rule 144 of the Securities Act.



IN WITNESS WHEREOF, the undersigned has caused this Power of

Attorney to be executed as of this _____ day of April, 2015.



/s/ Matthew Dallas

(Signature)



Matthew Dallas

(Print Name)